Metabolon to Showcase Quantose™ Test at American Association for Clinical Chemistry Clinical Lab Expo

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., announced today that Quantose™, its new prediabetes blood test, will be featured at the 2012 AACC Clinical Lab Expo, being held July 17-19 in Los Angeles, CA. Two poster presentations at the Expo will demonstrate the test’s utility to detect patients at risk for diabetes, even within the healthy range of hemoglobin A1C. In addition, information on Quantose™ and on the firm’s expanding diagnostic portfolio will be available at the Metabolon booth (#1150). For Metabolon, a pioneer in the field of metabolomics, Quantose™ represents the first in a line of several new diagnostic products the company plans to bring market, including metabolomics-driven tests focused on metabolic disease and cancer.